1. Home
  2. OVID vs DWSN Comparison

OVID vs DWSN Comparison

Compare OVID & DWSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • DWSN
  • Stock Information
  • Founded
  • OVID 2014
  • DWSN 1952
  • Country
  • OVID United States
  • DWSN United States
  • Employees
  • OVID N/A
  • DWSN N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • DWSN Oil & Gas Production
  • Sector
  • OVID Health Care
  • DWSN Energy
  • Exchange
  • OVID Nasdaq
  • DWSN Nasdaq
  • Market Cap
  • OVID 79.5M
  • DWSN N/A
  • IPO Year
  • OVID 2017
  • DWSN N/A
  • Fundamental
  • Price
  • OVID $1.17
  • DWSN $1.80
  • Analyst Decision
  • OVID Strong Buy
  • DWSN
  • Analyst Count
  • OVID 5
  • DWSN 0
  • Target Price
  • OVID $4.04
  • DWSN N/A
  • AVG Volume (30 Days)
  • OVID 112.3K
  • DWSN 12.7K
  • Earning Date
  • OVID 11-01-2024
  • DWSN 11-07-2024
  • Dividend Yield
  • OVID N/A
  • DWSN N/A
  • EPS Growth
  • OVID N/A
  • DWSN N/A
  • EPS
  • OVID N/A
  • DWSN N/A
  • Revenue
  • OVID $567,695.00
  • DWSN $91,315,000.00
  • Revenue This Year
  • OVID $22.49
  • DWSN N/A
  • Revenue Next Year
  • OVID $7,242.83
  • DWSN N/A
  • P/E Ratio
  • OVID N/A
  • DWSN N/A
  • Revenue Growth
  • OVID 186.16
  • DWSN 22.48
  • 52 Week Low
  • OVID $0.68
  • DWSN $1.27
  • 52 Week High
  • OVID $4.10
  • DWSN $2.26
  • Technical
  • Relative Strength Index (RSI)
  • OVID 54.79
  • DWSN 65.24
  • Support Level
  • OVID $1.03
  • DWSN $1.60
  • Resistance Level
  • OVID $1.19
  • DWSN $1.71
  • Average True Range (ATR)
  • OVID 0.07
  • DWSN 0.12
  • MACD
  • OVID 0.00
  • DWSN 0.02
  • Stochastic Oscillator
  • OVID 87.50
  • DWSN 93.94

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

Share on Social Networks: